| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.512 | 0.003 | 0.512 | Potassium channel large-conductance Ca-activated activator | 0.39 0.004 DBMET00814 | ||
| 0.433 | 0.013 | 0.433 | Death-associated protein kinase 3 inhibitor | 0.359 0.024 DBMET00814 | ||
| 0.403 | 0.004 | 0.403 | Potassium channel (Ca-activated) activator | 0.368 0.004 DBMET00814 | ||
| 0.403 | 0.008 | 0.403 | Protein kinase (CK1) inhibitor | |||
| 0.323 | 0.005 | 0.366 | Glutamate receptor agonist | 0.366 0.004 DBMET00814 | DBMET00814 | |
| 0.318 | 0.014 | 0.318 | Protein kinase (CK1) gamma 3 inhibitor | 0.192 0.052 DBMET00814 | ||
| 0.309 | 0.005 | 0.309 | MAP kinase kinase 3 inhibitor | |||
| 0.275 | 0.004 | 0.275 | Plasma kallikrein inhibitor | 0.058 0.009 DBMET00814 | ||
| 0.276 | 0.007 | 0.276 | MAP kinase kinase kinase inhibitor | 0.177 0.025 DBMET00814 | ||
| 0.276 | 0.007 | 0.331 | Nav1.6 sodium channel blocker | 0.331 0.005 DBMET00814 | DBMET00814 | |
| 0.299 | 0.041 | 0.299 | Anticonvulsant | 0.182 0.097 DBMET00814 | ||
| 0.258 | 0.006 | 0.258 | Glutamate (mGluR) agonist | 0.116 0.019 DBMET00814 | ||
| 0.274 | 0.032 | 0.274 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.146 0.08 DBMET00814 | ||
| 0.296 | 0.067 | 0.296 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.264 | 0.039 | 0.264 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.209 0.07 DBMET00814 | ||
| 0.33 | 0.109 | 0.33 | MAP kinase kinase 6 inhibitor | |||
| 0.223 | 0.004 | 0.223 | Glutamate (mGluR group II) agonist | 0.124 0.005 DBMET00814 | ||
| 0.26 | 0.042 | 0.26 | CDC-like kinase 2 inhibitor | 0.203 0.065 DBMET00814 | ||
| 0.259 | 0.043 | 0.259 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.129 0.106 DBMET00814 | ||
| 0.246 | 0.031 | 0.246 | Protein kinase (CK1) gamma inhibitor | 0.116 0.094 DBMET00814 | ||
| 0.218 | 0.004 | 0.218 | Glutamate (mGluR2) agonist | 0.114 0.005 DBMET00814 | ||
| 0.218 | 0.005 | 0.218 | Kallikrein inhibitor | 0.055 0.026 DBMET00814 | ||
| 0.291 | 0.08 | 0.33 | Interleukin 2 agonist | 0.33 0.055 DBMET00814 | DBMET00814 | |
| 0.234 | 0.024 | 0.234 | Protein kinase (CK1) gamma 2 inhibitor | 0.11 0.073 DBMET00814 | ||
| 0.353 | 0.147 | 0.37 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.37 0.129 DBMET00814 | DBMET00814 | |
| 0.234 | 0.032 | 0.234 | Protein kinase (CK1) gamma 1 inhibitor | 0.111 0.108 DBMET00814 | ||
| 0.24 | 0.054 | 0.24 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.198 0.078 DBMET00814 | ||
| 0.28 | 0.094 | 0.28 | Immunomodulator | |||
| 0.22 | 0.036 | 0.22 | Polo-like kinase-3 inhibitor | |||
| 0.21 | 0.029 | 0.213 | Hemostatic | 0.213 0.028 DBMET00814 | DBMET00814 | |
| 0.179 | 0.007 | 0.179 | Myeloperoxidase inhibitor | 0.155 0.01 DBMET00814 | ||
| 0.176 | 0.016 | 0.18 | Multidrug resistance-associated protein 1 inhibitor | 0.18 0.015 DBMET00814 | DBMET00814 | |
| 0.17 | 0.017 | 0.17 | Hepatocyte growth factor antagonist | 0.087 0.067 DBMET00814 | ||
| 0.154 | 0.004 | 0.154 | Stearoyl-CoA desaturase inhibitor | 0.069 0.014 DBMET00814 | ||
| 0.188 | 0.045 | 0.188 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.207 | 0.065 | 0.207 | I kappa B kinase epsilon inhibitor | 0.201 0.07 DBMET00814 | ||
| 0.18 | 0.04 | 0.273 | Cell wall synthesis inhibitor | 0.273 0.012 DBMET00814 | DBMET00814 | |
| 0.283 | 0.148 | 0.518 | Antibacterial | 0.518 0.036 DBMET00814 | DBMET00814 | |
| 0.134 | 0.005 | 0.134 | Gonadotropin-releasing hormone receptor antagonist | 0.101 0.008 DBMET00814 | ||
| 0.197 | 0.069 | 0.197 | TRKC antagonist | |||
| 0.139 | 0.011 | 0.139 | Amidase inhibitor | 0.086 0.033 DBMET00814 | ||
| 0.205 | 0.081 | 0.205 | Nitric-oxide synthase stimulant | 0.177 0.134 DBMET00814 | ||
| 0.163 | 0.046 | 0.163 | Sodium channel (voltage-gated) blocker | |||
| 0.13 | 0.015 | 0.13 | Carbonic anhydrase VA inhibitor | 0.113 0.02 DBMET00814 | ||
| 0.132 | 0.019 | 0.132 | Carbonic anhydrase V inhibitor | 0.111 0.024 DBMET00814 | ||
| 0.216 | 0.106 | 0.225 | Interleukin agonist | 0.225 0.098 DBMET00814 | DBMET00814 | |
| 0.168 | 0.057 | 0.168 | Heat shock protein 90 antagonist | |||
| 0.115 | 0.007 | 0.115 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.093 0.013 DBMET00814 | ||
| 0.11 | 0.004 | 0.11 | Glutamate (mGluR group II) antagonist | 0.108 0.004 DBMET00814 | ||
| 0.157 | 0.054 | 0.157 | Sodium channel blocker | |||
| 0.119 | 0.016 | 0.119 | CDC7 inhibitor | 0.061 0.055 DBMET00814 | ||
| 0.186 | 0.084 | 0.186 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.178 | 0.076 | 0.178 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.16 | 0.06 | 0.16 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.105 | 0.005 | 0.154 | Guanylate cyclase stimulant | 0.154 0.004 DBMET00814 | DBMET00814 | |
| 0.109 | 0.01 | 0.109 | Phosphodiesterase VIII inhibitor | 0.099 0.015 DBMET00814 | ||
| 0.101 | 0.007 | 0.101 | Lysine-specific demethylase 1A inhibitor | 0.077 0.014 DBMET00814 | ||
| 0.148 | 0.054 | 0.148 | Protein kinase (CK1) delta inhibitor | |||
| 0.097 | 0.004 | 0.097 | Glutamate (mGluR2) antagonist | 0.084 0.004 DBMET00814 | ||
| 0.15 | 0.059 | 0.15 | Cyclin-dependent kinase 7 inhibitor | |||
| 0.154 | 0.064 | 0.154 | Glycogen synthase kinase-3 alpha inhibitor | 0.103 0.102 DBMET00814 | ||
| 0.133 | 0.046 | 0.133 | MAP kinase 13 inhibitor | |||
| 0.097 | 0.009 | 0.097 | Oleamide hydrolase inhibitor | 0.057 0.022 DBMET00814 | ||
| 0.245 | 0.159 | 0.245 | GABA C receptor rho-3 antagonist | 0.232 0.172 DBMET00814 | ||
| 0.164 | 0.081 | 0.164 | 3C-like protease (Human coronavirus) inhibitor | 0.164 0.081 DBMET00814 | ||
| 0.185 | 0.103 | 0.185 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.123 | 0.043 | 0.173 | Beta glucuronidase inhibitor | 0.173 0.017 DBMET00814 | DBMET00814 | |
| 0.125 | 0.045 | 0.125 | Check point kinase 2 inhibitor | |||
| 0.112 | 0.036 | 0.112 | Pim-3 kinase inhibitor | |||
| 0.125 | 0.05 | 0.228 | Ferrochelatase inhibitor | 0.228 0.017 DBMET00814 | DBMET00814 | |
| 0.146 | 0.072 | 0.146 | Protein kinase C nu inhibitor | |||
| 0.112 | 0.039 | 0.112 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.1 | 0.036 | 0.1 | Janus tyrosine kinase 2 inhibitor | |||
| 0.173 | 0.11 | 0.173 | Histone acetyltransferase inhibitor | 0.156 0.131 DBMET00814 | ||
| 0.155 | 0.093 | 0.155 | LIM domain kinase 1 inhibitor | |||
| 0.111 | 0.053 | 0.14 | Toll-Like receptor 4 antagonist | 0.14 0.027 DBMET00814 | DBMET00814 | |
| 0.062 | 0.004 | 0.062 | MAP3K8 inhibitor | 0.047 0.005 DBMET00814 | ||
| 0.081 | 0.024 | 0.081 | Exportin-1 inhibitor | 0.063 0.062 DBMET00814 | ||
| 0.095 | 0.039 | 0.095 | mTOR complex 2 inhibitor | 0.088 0.052 DBMET00814 | ||
| 0.082 | 0.029 | 0.082 | Histone deacetylase inhibitor | |||
| 0.099 | 0.049 | 0.099 | Potassium channel activator | |||
| 0.082 | 0.033 | 0.082 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.119 | 0.071 | 0.119 | MAP kinase 12 inhibitor | |||
| 0.062 | 0.014 | 0.066 | Dopamine beta hydroxylase inhibitor | 0.066 0.01 DBMET00814 | DBMET00814 | |
| 0.156 | 0.108 | 0.156 | Clk dual-specificity kinase inhibitor | |||
| 0.212 | 0.166 | 0.212 | Ca(v)3.3 blocker | |||
| 0.079 | 0.037 | 0.079 | Potassium channel (Tandem pore domain) blocker | 0.07 0.063 DBMET00814 | ||
| 0.057 | 0.017 | 0.057 | Benzodiazepine inverse agonist | 0.052 0.023 DBMET00814 | ||
| 0.26 | 0.222 | 0.26 | MAP kinase 1 inhibitor | |||
| 0.052 | 0.017 | 0.052 | Factor XIa inhibitor | |||
| 0.065 | 0.033 | 0.065 | Heat shock protein 90 beta antagonist | |||
| 0.066 | 0.035 | 0.066 | Aminopeptidase microsomal inhibitor | 0.06 0.04 DBMET00814 | ||
| 0.139 | 0.11 | 0.139 | CDC-like kinase 4 inhibitor | |||
| 0.063 | 0.034 | 0.063 | Gonadotropin-releasing hormone receptor agonist | 0.056 0.049 DBMET00814 | ||
| 0.108 | 0.08 | 0.108 | Beta amyloid protein antagonist | |||
| 0.033 | 0.006 | 0.057 | Guanylate cyclase 1 stimulant | 0.057 0.005 DBMET00814 | DBMET00814 | |
| 0.045 | 0.018 | 0.045 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.059 | 0.033 | 0.059 | Sphingosine kinase 2 inhibitor | |||
| 0.075 | 0.051 | 0.075 | Protein kinase B gamma inhibitor | |||
| 0.066 | 0.044 | 0.066 | Tyk2 inhibitor | |||
| 0.091 | 0.07 | 0.154 | Creatine kinase inhibitor | 0.154 0.022 DBMET00814 | DBMET00814 | |
| 0.191 | 0.17 | 0.197 | 5 Hydroxytryptamine uptake stimulant | 0.197 0.157 DBMET00814 | DBMET00814 | |
| 0.054 | 0.037 | 0.084 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.084 0.014 DBMET00814 | DBMET00814 | |
| 0.052 | 0.036 | 0.052 | Phosphodiesterase 7A inhibitor | |||
| 0.047 | 0.033 | 0.047 | CC chemokine 4 receptor antagonist | |||
| 0.047 | 0.034 | 0.047 | Aminopeptidase N inhibitor | 0.042 0.039 DBMET00814 | ||
| 0.034 | 0.021 | 0.039 | Estrogen-related receptor alpha antagonist | 0.039 0.018 DBMET00814 | DBMET00814 | |
| 0.044 | 0.031 | 0.044 | Dipeptidyl peptidase IV inhibitor | |||
| 0.051 | 0.039 | 0.051 | Dipeptidyl peptidase inhibitor | |||
| 0.067 | 0.056 | 0.067 | Polo-like kinase-2 inhibitor | |||
| 0.094 | 0.084 | 0.094 | GABA receptor agonist | |||
| 0.073 | 0.062 | 0.157 | Macrophage migration inhibitory factor inhibitor | 0.157 0.013 DBMET00814 | DBMET00814 | |
| 0.078 | 0.068 | 0.078 | GABA A receptor agonist | |||
| 0.187 | 0.178 | 0.194 | Insulysin inhibitor | 0.194 0.167 DBMET00814 | DBMET00814 | |
| 0.057 | 0.048 | 0.057 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.068 | 0.059 | 0.068 | Rho-associated kinase II inhibitor | |||
| 0.204 | 0.196 | 0.204 | Toll-Like receptor 7 agonist | |||
| 0.036 | 0.028 | 0.036 | Factor XIIIa inhibitor | |||
| 0.066 | 0.06 | 0.066 | Histone deacetylase SIRT2 inhibitor | |||
| 0.027 | 0.022 | 0.027 | Hedgehog signaling activator | |||
| 0.085 | 0.08 | 0.267 | Xanthine oxidase inhibitor | 0.267 0.01 DBMET00814 | DBMET00814 | |
| 0.017 | 0.014 | 0.017 | Complement factor D inhibitor | |||
| 0.093 | 0.091 | 0.116 | DOPA decarboxylase inhibitor | 0.116 0.05 DBMET00814 | DBMET00814 | |
| 0.081 | 0.08 | 0.081 | Pim-1 kinase inhibitor | |||
| 0.127 | 0.125 | 0.127 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.089 | 0.088 | 0.089 | Glutamate (mGluR7) agonist | |||
| 0.231 | 0.235 | 0.37 | Apoptosis agonist | 0.37 0.128 DBMET00814 | DBMET00814 | |
| 0.021 | 0.027 | 0.023 | Glutamate (mGluR1) agonist | 0.023 0.022 DBMET00814 | DBMET00814 | |
| 0.043 | 0.055 | 0.069 | Aromatase inhibitor | 0.069 0.035 DBMET00814 | DBMET00814 | |
| 0.233 | 0.252 | 0.367 | 5 Hydroxytryptamine release inhibitor | 0.367 0.102 DBMET00814 | DBMET00814 | |
| 0.077 | 0.1 | 0.144 | GABA C receptor agonist | 0.144 0.036 DBMET00814 | DBMET00814 | |
| 0.014 | 0.04 | 0.039 | Lysophosphatidic acid 1 receptor antagonist | 0.039 0.005 DBMET00814 | DBMET00814 | |
| 0.049 | 0.075 | 0.085 | Lipase inhibitor | 0.085 0.038 DBMET00814 | DBMET00814 | |
| 0.024 | 0.051 | 0.066 | RNA-directed RNA polymerase inhibitor | 0.066 0.008 DBMET00814 | DBMET00814 | |
| 0.041 | 0.068 | 0.053 | Alpha-mannosidase inhibitor | 0.053 0.038 DBMET00814 | DBMET00814 | |
| 0.158 | 0.188 | 0.225 | DNA synthesis inhibitor | 0.225 0.089 DBMET00814 | DBMET00814 | |
| 0.041 | 0.071 | 0.091 | Neuraminidase inhibitor | 0.091 0.019 DBMET00814 | DBMET00814 | |
| 0.047 | 0.078 | 0.07 | Pregnane X receptor antagonist | 0.07 0.014 DBMET00814 | DBMET00814 | |
| 0.031 | 0.071 | 0.25 | Prostaglandin E2 antagonist | 0.25 0.005 DBMET00814 | DBMET00814 | |
| 0.006 | 0.046 | 0.022 | Egl nine homolog 1 inhibitor | 0.022 0.005 DBMET00814 | DBMET00814 | |
| 0.016 | 0.057 | 0.038 | Protocollagen prolyl hydroxylase inhibitor | 0.038 0.009 DBMET00814 | DBMET00814 | |
| 0.031 | 0.075 | 0.143 | Xanthine dehydrogenase inhibitor | 0.143 0.008 DBMET00814 | DBMET00814 | |
| 0.052 | 0.097 | 0.098 | HIV-1 integrase inhibitor | 0.098 0.026 DBMET00814 | DBMET00814 | |
| 0.079 | 0.124 | 0.198 | Amylase inhibitor | 0.198 0.045 DBMET00814 | DBMET00814 | |
| 0.031 | 0.076 | 0.051 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.051 0.014 DBMET00814 | DBMET00814 | |
| 0.005 | 0.054 | 0.014 | Egl nine homolog 3 inhibitor | 0.014 0.006 DBMET00814 | DBMET00814 | |
| 0.027 | 0.076 | 0.041 | Mannosidase inhibitor | 0.041 0.039 DBMET00814 | DBMET00814 | |
| 0.008 | 0.058 | 0.025 | Nicotinic acid receptor 1 antagonist | 0.025 0.005 DBMET00814 | DBMET00814 | |
| 0.063 | 0.117 | 0.104 | Alcohol dehydrogenase inhibitor | 0.104 0.048 DBMET00814 | DBMET00814 | |
| 0.021 | 0.085 | 0.034 | Glutamate (mGluR3) antagonist | 0.034 0.03 DBMET00814 | DBMET00814 | |
| 0.015 | 0.086 | 0.037 | Purinergic P2Y14 antagonist | 0.037 0.014 DBMET00814 | DBMET00814 | |
| 0.012 | 0.084 | 0.057 | HCV NS5B polymerase inhibitor | 0.057 0.009 DBMET00814 | DBMET00814 | |
| 0.061 | 0.136 | 0.117 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.117 0.041 DBMET00814 | DBMET00814 | |
| 0.061 | 0.137 | 0.107 | Protein kinase (CK2) alpha inhibitor | 0.107 0.071 DBMET00814 | DBMET00814 | |
| 0.035 | 0.117 | 0.068 | Leukotriene synthesis inhibitor | 0.068 0.046 DBMET00814 | DBMET00814 | |
| 0.017 | 0.115 | 0.048 | Angiotensin AT1 receptor antagonist | 0.048 0.02 DBMET00814 | DBMET00814 | |
| 0.027 | 0.127 | 0.07 | Aconitate hydratase inhibitor | 0.07 0.018 DBMET00814 | DBMET00814 | |
| 0.016 | 0.118 | 0.035 | Angiotensin II receptor antagonist | 0.035 0.022 DBMET00814 | DBMET00814 | |
| 0.022 | 0.127 | 0.036 | Glutamate (mGluR8) antagonist | 0.036 0.023 DBMET00814 | DBMET00814 | |
| 0.206 | 0.312 | 0.27 | Caspase 9 stimulant | 0.27 0.228 DBMET00814 | DBMET00814 | |
| 0.004 | 0.112 | 0.021 | Angiotensin AT1A receptor antagonist | 0.021 0.018 DBMET00814 | DBMET00814 | |
| 0.011 | 0.118 | 0.053 | Carbonic anhydrase XII inhibitor | 0.053 0.036 DBMET00814 | DBMET00814 | |
| 0.004 | 0.113 | 0.121 | Prostaglandin EP1 antagonist | 0.121 0.004 DBMET00814 | DBMET00814 | |
| 0.035 | 0.144 | 0.083 | Glutamate decarboxylase inhibitor | 0.083 0.041 DBMET00814 | DBMET00814 | |
| 0.041 | 0.156 | 0.09 | Protein kinase (CK2) inhibitor | 0.09 0.073 DBMET00814 | DBMET00814 | |
| 0.046 | 0.164 | 0.084 | 5-Lipoxygenase inhibitor | 0.084 0.076 DBMET00814 | DBMET00814 | |
| 0.017 | 0.144 | 0.175 | Prostaglandin antagonist | 0.175 0.008 DBMET00814 | DBMET00814 | |
| 0.051 | 0.183 | 0.092 | Triose-phosphate isomerase inhibitor | 0.092 0.057 DBMET00814 | DBMET00814 | |
| 0.038 | 0.172 | 0.1 | Monophenol monooxygenase inhibitor | 0.1 0.076 DBMET00814 | DBMET00814 | |
| 0.031 | 0.165 | 0.069 | CDC25B inhibitor | 0.069 0.039 DBMET00814 | DBMET00814 | |
| 0.009 | 0.146 | 0.034 | Nicotinic acid receptor 2 antagonist | 0.034 0.009 DBMET00814 | DBMET00814 | |
| 0.1 | 0.24 | 0.161 | Succinate dehydrogenase inhibitor | 0.161 0.093 DBMET00814 | DBMET00814 | |
| 0.01 | 0.156 | 0.066 | Nicotinic acid receptor agonist | 0.066 0.009 DBMET00814 | DBMET00814 | |
| 0.016 | 0.174 | 0.058 | Dihydroorotate dehydrogenase inhibitor | 0.058 0.03 DBMET00814 | DBMET00814 | |
| 0.018 | 0.184 | 0.043 | Neuraminidase (Influenza A) inhibitor | 0.043 0.037 DBMET00814 | DBMET00814 | |
| 0.028 | 0.199 | 0.058 | Prostaglandin F2 alpha antagonist | 0.058 0.051 DBMET00814 | DBMET00814 | |
| 0.006 | 0.188 | 0.031 | Kynurenine 3 monooxygenase inhibitor | 0.031 0.015 DBMET00814 | DBMET00814 | |
| 0.009 | 0.204 | 0.09 | Nicotinic acid receptor 2 agonist | 0.09 0.006 DBMET00814 | DBMET00814 | |
| 0.038 | 0.242 | 0.103 | Glutamate receptor antagonist | 0.103 0.093 DBMET00814 | DBMET00814 | |
| 0.037 | 0.245 | 0.112 | Cholesterol synthesis inhibitor | 0.112 0.073 DBMET00814 | DBMET00814 | |
| 0.016 | 0.226 | 0.062 | Prostaglandin-E synthase inhibitor | 0.062 0.059 DBMET00814 | DBMET00814 | |
| 0.005 | 0.235 | 0.043 | Urate transporter 1 inhibitor | 0.043 0.023 DBMET00814 | DBMET00814 | |
| 0.142 | 0.375 | 0.245 | Cyclophilin D inhibitor | 0.245 0.218 DBMET00814 | DBMET00814 | |
| 0.044 | 0.278 | 0.125 | Alpha-N-acetylglucosaminidase inhibitor | 0.125 0.073 DBMET00814 | DBMET00814 | |
| 0.035 | 0.283 | 0.358 | Uric acid excretion stimulant | 0.358 0.004 DBMET00814 | DBMET00814 | |
| 0.1 | 0.359 | 0.13 | Ca2+-transporting ATPase inhibitor | 0.13 0.12 DBMET00814 | DBMET00814 | |
| 0.071 | 0.478 | 0.21 | Histamine release inhibitor | 0.21 0.191 DBMET00814 | DBMET00814 | |
| 0.076 | 0.521 | 0.371 | Caspase 3 stimulant | 0.371 0.053 DBMET00814 | DBMET00814 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |